Login / Signup

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma.

Wei-Chen LeeHao-Chien HungJin-Chiao LeeYu-Chao WangChih-Hsien ChengTsung-Han WuChen-Fang LeeTing-Jung WuHong-Shiue ChouKun-Ming Chan
Published in: Cancer reports (Hoboken, N.J.) (2020)
Immunosuppressor cells were not altered by sorafeinb. Patients' survival was improved if N/L ≥ 2.5 was reduced to <2.5 by TACE.
Keyphrases
  • end stage renal disease
  • induced apoptosis
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • cell cycle arrest
  • patient reported outcomes
  • combination therapy
  • pi k akt